Drug Profile
Research programme: antifungals - TopoTarget UK
Alternative Names: Antifungals research programme - TopoTargets UKLatest Information Update: 22 Oct 2002
Price :
$50
*
At a glance
- Originator Imperial College of Science, Technology and Medicine; TopoTarget UK
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Candidiasis
Most Recent Events
- 22 Oct 2002 Discontinued - Preclinical for Candidiasis in United Kingdom (unspecified route)
- 18 Oct 2002 Prolifix has been acquired by TopoTarget
- 05 Oct 2001 Preclinical development for Candidiasis in United Kingdom (Unknown route)